Bengaluru, April 20, 2016: Solvay Aroma Performance, the worldwide leader in diphenol and derivatives intermediates, announces its plan to build an additional production capacity of Hydroquinone (HQ) in China starting-up in 2018. This investment will be based on an innovative and environmental friendly technology.
In addition, the Global Business Unit will extend its worldwide Methyl hydroquinone (MEHQ also referred as PMP – paramethoxyphenol) capacity. Both projects will support Solvay captive needs as well as the growth of HQ and MEHQ markets, particularly in Asia.
“This decision will strengthen the company leading position in growing markets like Monomer inhibition with a full range of solutions including PTZ coming from Cytec acquisition, Specialty polymers and Coatings applications as well as Food & Feed antioxidants on which we are positioning ourselves” says Dominique Rage, President of the GBU. “This major capacity increase enhances our reliability towards our customers and will allow for new growth opportunities” he adds.
Corporate Comm India (CCI Newswire)
Pearson Syndrome is an extremely rare condition and the prevalence is approximately 1 in a…
A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…
People who smoke are also at much higher risk of developing diabetes compared to non-smokers…
17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…
Lonavala, November 12, 2024: As the global cancer burden rises to 30 million cases by…
The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…